Meprobamate and aspirin and Hypomagnesemia - a phase IV clinical study of FDA data


We study 171 people who take Meprobamate and aspirin or have Hypomagnesemia. No report of Hypomagnesemia is found in people who take Meprobamate and aspirin.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 08, 2022

No report is found.

What is Meprobamate And Aspirin?

Meprobamate and aspirin has active ingredients of aspirin; meprobamate.

What is Hypomagnesemia?

Hypomagnesemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood) is found to be associated with 4 conditions by eHealthMe.

Do you take Meprobamate and aspirin and have Hypomagnesemia?

Check whether Hypomagnesemia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Hypomagnesemia and when was it recovered:

Expand to all the drugs that have ingredients of aspirin; meprobamate:

Alternative drugs to, pros and cons of Meprobamate and aspirin:

Hypomagnesemia treatments and more:

COVID vaccines that are related to Hypomagnesemia:

All the drugs that are associated with Hypomagnesemia:

All the conditions that are associated with Hypomagnesemia:

How the study uses the data?

The study uses data from the FDA. It is based on aspirin; meprobamate (the active ingredients of Meprobamate and aspirin) and Meprobamate and aspirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: